June 9, 2026

Pfizer’s Hympavzi secures FDA expanded indications for haemophilia

​Pfizer has received approval from the FDA for an expanded indication of Hympavzi for the treatment of haemophilia A or...

June 8, 2026

Insulet reports new data for Omnipod 6 and FCL systems

​Insulet has reported results from its STRIVE and EVOLUTION 3 studies, assessing its upcoming Omnipod 6 AID system and a...

June 8, 2026

Novo Nordisk reports Phase II data for zenagamtide in diabetes

​Novo Nordisk has reported results from its Phase II study of zenagamtide, showing drops in blood sugar and body weight...

June 8, 2026

EC grants marketing authorisation for IntraBio’s Aqneursa

​The European Commission (EC) has granted marketing authorisation for IntraBio’s Aqneursa to treat neurological symptoms of NPC.The post EC grants...

June 5, 2026

First patient dosed in Onchilles’ Phase I/II trial of N17350

​Onchilles Pharma has dosed the first patient in its Phase I/II clinical trial of N17350 for patients with advanced solid...

June 5, 2026

FDA approves GE HealthCare’s MIM Contour ProtégéAI+ 2.0 software

​GE HealthCare has received 510(k) clearance from the FDA for its AI-powered MIM Contour ProtégéAI+ 2.0 software.The post FDA approves...

June 5, 2026

Biogen’s salanersen gains FDA breakthrough therapy designation for SMA

​Biogen has received the breakthrough therapy designation from the FDA for salanersen (BIIB115), an investigational treatment for SMA.The post Biogen’s...

June 4, 2026

Insulet launches algorithm improvements for Omnipod 5 AID system in US

​Insulet has begun distributing an updated version of its Omnipod 5 AID System across the US, following 510(k) clearance in...

June 4, 2026

J&J’s nipocalimab meets primary endpoint in Phase II JASMINE study

​J&J has reported that its monoclonal antibody, nipocalimab, met the primary endpoint in the Phase II JASMINE study by reducing...

Connect with us

Whether you are a professional looking for a new job or a representative of an organization who needs workforce solutions - we are here to help.